하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
Seoul, South Korea – October 13, 2025 – HIRONIC Inc. (CEO: Jinwoo Lee), a leading manufacturer of aesthetic medical devices, announced the successful completion of its ‘SYNERJET Hands-On Seminar’ held on September 30 at Classone Clinic in Seoul.
The seminar aimed to deepen medical professionals’ understanding of SYNERJET and to foster clinical knowledge exchange. Reflecting the high interest in HIRONIC’s needle-free microjet technology, the event featured in-depth lectures and live demonstrations, followed by a dynamic Q&A session filled with active discussions.
SYNERJET is a non-invasive device that delivers active ingredients into the skin using a high-pressure jet injection system. By eliminating the need for needles, the device minimizes pain, bruising, and bleeding while maximizing absorption efficiency—aligning perfectly with the current trend in aesthetic medicine that emphasizes both safety and efficacy. The device was met with favorable feedback from attending physicians.
A HIRONIC spokesperson commented, “The seminar reaffirmed the strong interest of clinical professionals in our SYNERJET technology,” and added, “We will continue engaging with medical professionals across various regions through localized seminars, building mutual trust and reinforcing our clinical partnerships.”
